BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
47 hedge funds and large institutions have $2.19M invested in BRAINSTORM CELL THERAPUTC in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
+1
Holders Change %
+2.17%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
10
Closed
6
Calls
$66K
Puts
$1K
Net Calls
+$65K
Net Calls Change
+$90K
Top Buyers
| 1 |
GCP
1
GSA Capital Partners
London,
United Kingdom
|
$63K |
| 2 |
KWA
2
Kingswood Wealth Advisors
San Diego,
California
|
$45.8K |
| 3 |
3
BlackRock
New York
|
$276K |
| 4 |
4
Jane Street
New York
|
$10.6K |
| 5 |
5
Group One Trading
Chicago,
Illinois
|
$17.3K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Fidelity Investments
Boston,
Massachusetts
| – | -$35 | -8 | Closed |
|